Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study. [electronic resource] by
- Reinhart, K
- Menges, T
- Gardlund, B
- Harm Zwaveling, J
- Smithes, M
- Vincent, J L
- Tellado, J M
- Salgado-Remigio, A
- Zimlichman, R
- Withington, S
- Tschaikowsky, K
- Brase, R
- Damas, P
- Kupper, H
- Kempeni, J
- Eiselstein, J
- Kaul, M
Producer: 20010614
In:
Critical care medicine vol. 29
Availability: No items available.
|